Clinical Reviews in Allergy & Immunology

, Volume 48, Issue 1, pp 1–6 | Cite as

Definition of Critical Asthma Syndromes

  • Nicholas Kenyon
  • Amir A. Zeki
  • Timothy E. Albertson
  • Samuel LouieEmail author


Urgent visits to the clinic and emergency department for acute severe asthma exacerbations are all too frequent. Existing national guidelines do not present consistent or specific recommendations for the evaluation and treatment of individual asthma patients in respiratory distress. In this vein, we propose the term "critical asthma syndrome" (CAS) to describe any child or adult who is at high risk for fatal asthma. Acute severe asthma, refractory asthma, status asthmaticus, and near-fatal asthma all describe CAS where physical exhaustion from the overwhelming work of breathing leads to respiratory arrest and death from hypoxia or related complications. The authors of this supplement seek to emphasize the importance of early recognition, prompt and coordinated evaluation, and treatment of CAS in the emergency department, hospital, and intensive care units by experienced healthcare provider teams. CAS is not severe persistent asthma where control of symptoms and prevention of exacerbations are targets of chronic disease management in the outpatient setting. The authors address the distinctions between the two entities throughout the supplement, and elaborate on the considerations important in the care of a critically ill patient, including the common errors to avoid. In addition, gaps in knowledge and clinical experience in regards to critical asthma are highlighted. Knowledge gaps include a lack of understanding of how to recognize CAS, how to coordinate and integrate hospital and outpatient resources, when to further phenotype patients with critical asthma in order to facilitate effective treatment, and how to prevent future acute exacerbations. Lastly, CAS is complicated by the fact that asthma care in diverse healthcare settings is haphazard. We recommend that primary care physicians refer patients promptly to an asthma specialist for consultation to reduce the frequency of acute exacerbations and prevent the development of CAS.


Critical asthma Fatal asthma Near fatal asthma Status asthmaticus Severe persistent asthma 


  1. 1.
    National Asthma Education and Prevention Program (2007) Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120:S94–S138CrossRefGoogle Scholar
  2. 2.
    Kroegel C (2009) Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 5:239–249PubMedCrossRefGoogle Scholar
  3. 3.
    Shapiro JM (2001) Intensive care management of status asthmaticus. Chest 120:1439–1441PubMedCrossRefGoogle Scholar
  4. 4.
    Tsai CL, Lee WY, Hanania NA, Camargo CA (2012) Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol 129:1252–1258PubMedCrossRefGoogle Scholar
  5. 5.
    Sly RM (1984) Increases in deaths from asthma. Ann Allergy 53:20–25PubMedGoogle Scholar
  6. 6.
    Greiling AK, Boss LP, Wheeler LS (2005) A preliminary investigation of asthma mortality in schools. J Sch Health 75:286–290PubMedCrossRefGoogle Scholar
  7. 7.
    Moorman JE, Akinbami LJ, Bailey CM et al. (2012) National surveillance of asthma: United States, 2001–2010. DHHS Publincation No. (PHS) 2013–1419. 3:1–67Google Scholar
  8. 8.
    Fuhlbrigge AL, Adams RJ, Guilbert TW et al (2002) The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 166:1044–1049PubMedCrossRefGoogle Scholar
  9. 9.
    Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST (2007) Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119:1454–1461PubMedCrossRefGoogle Scholar
  10. 10.
    Moore WC, Bleecker ER, Curran-Everett D et al (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119:405–413PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    American Thoracic Society (2000) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341–2351CrossRefGoogle Scholar
  12. 12.
    Bush A, Zar HJ (2011) WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 11:115–121PubMedCrossRefGoogle Scholar
  13. 13.
    Busse WW (2011) Asthma diagnosis and treatment: filling in the information gaps. J Allergy Clin Immunol 128:740–750PubMedCrossRefGoogle Scholar
  14. 14.
    Wenzel SE, Schwartz LB, Langmack EL et al (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160:1001–1008PubMedCrossRefGoogle Scholar
  15. 15.
    Woodruff PG, Modrek B, Choy DF et al (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Amelink M, de Nijs SB, de Groot JC, van Tilburg PM et al (2013) Three phenotypes of adult-onset asthma. Allergy 68:674–680PubMedCrossRefGoogle Scholar
  17. 17.
    Kim TB, Jang HS, Kwon JS et al (2013) Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 41(6):1308–1314PubMedCrossRefGoogle Scholar
  18. 18.
    Fitzpatrick AM, Teague WG, Meyers DA, National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program et al (2011) Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 127(2):382–389PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Patrawalla PA, Kazeros L, Rogers Y et al (2012) Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. PLoS One 7(9):e44540PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Turner-Warwick M (1971) Provoking factors in asthma. British J Dis Chest 65:1–20CrossRefGoogle Scholar
  21. 21.
    Ayres JG, Miles JF, Barnes PJ (1998) Brittle asthma. Thorax 53:315–321PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    McFadden ER Jr (1991) Fatal and near-fatal asthma. N Engl J Med 324:409–411PubMedCrossRefGoogle Scholar
  23. 23.
    McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelle L, Jain S (2009) Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis 13:57. doi: 10.1186/1471-2334-13-57 CrossRefGoogle Scholar
  24. 24.
    Mortensen E, Louie J, Pertowski C et al (2013) Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1) — California, 2009. Influenza Other Respir Viruses. doi: 10.1111/irv.12120 PubMedGoogle Scholar
  25. 25.
    Jeffery PK (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164:S28–S38PubMedCrossRefGoogle Scholar
  26. 26.
    Mauadk T, Bel EH, Sterk PJ (2007) Asthma therapy and airway remodeling. J Allergy Clin Immunol 120:997–1009CrossRefGoogle Scholar
  27. 27.
    Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche RW (1990) Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3:507–511PubMedCrossRefGoogle Scholar
  28. 28.
    Martin RJ, Szefler SJ, King TS et al (2007) The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119:73–80PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nicholas Kenyon
    • 1
  • Amir A. Zeki
    • 1
  • Timothy E. Albertson
    • 1
    • 2
  • Samuel Louie
    • 1
    • 3
    Email author
  1. 1.Division of Pulmonary, Critical Care, Sleep Medicine, Department of MedicineUniversity of California, DavisDavisUSA
  2. 2.VA Northern California Healthcare SystemVA Mather HospitalMatherUSA
  3. 3.University of California, DavisSacramentoUSA

Personalised recommendations